Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity.
BACKGROUND:Nyaditum resae® (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in a murine experimental model that develop human-lik...
Main Authors: | Eva Montané, Ana Maria Barriocanal, Ana Lucía Arellano, Angelica Valderrama, Yolanda Sanz, Nuria Perez-Alvarez, Paula Cardona, Cristina Vilaplana, Pere-Joan Cardona |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5300153?pdf=render |
Similar Items
-
Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis development
by: Nestani Tukvadze, et al.
Published: (2016-01-01) -
Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.
by: Andre S Nell, et al.
Published: (2014-01-01) -
Experimental animal modelling for TB vaccine development
by: Pere-Joan Cardona, et al.
Published: (2017-03-01) -
Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis.
by: Cristina Vilaplana, et al.
Published: (2011-01-01) -
Multiple consecutive infections might explain the lack of protection by BCG.
by: Pere-Joan Cardona, et al.
Published: (2014-01-01)